Clinical Trials Logo

Recurrent Malignancy clinical trials

View clinical trials related to Recurrent Malignancy.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03557749 Terminated - Clinical trials for Cytokine Release Syndrome

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Start date: September 21, 2018
Phase:
Study type: Observational

This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbiota, and their interactions. Fluid (including but not limited to, blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in, processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC) Translational Therapy Lab (TTL).